Literature DB >> 26091850

Polypathology and dementia after brain trauma: Does brain injury trigger distinct neurodegenerative diseases, or should they be classified together as traumatic encephalopathy?

Patricia M Washington1, Sonia Villapol2, Mark P Burns3.   

Abstract

Neuropathological studies of human traumatic brain injury (TBI) cases have described amyloid plaques acutely after a single severe TBI, and tau pathology after repeat mild TBI (mTBI). This has helped drive the hypothesis that a single moderate to severe TBI increases the risk of developing late-onset Alzheimer's disease (AD), while repeat mTBI increases the risk of developing chronic traumatic encephalopathy (CTE). In this review we critically assess this position-examining epidemiological and case control human studies, neuropathological evidence, and preclinical data. Epidemiological studies emphasize that TBI is associated with the increased risk of developing multiple types of dementia, not just AD-type dementia, and that TBI can also trigger other neurodegenerative conditions such as Parkinson's disease. Further, human post-mortem studies on both single TBI and repeat mTBI can show combinations of amyloid, tau, TDP-43, and Lewy body pathology indicating that the neuropathology of TBI is best described as a 'polypathology'. Preclinical studies confirm that multiple proteins associated with the development of neurodegenerative disease accumulate in the brain after TBI. The chronic sequelae of both single TBI and repeat mTBI share common neuropathological features and clinical symptoms of classically defined neurodegenerative disorders. However, while the spectrum of chronic cognitive and neurobehavioral disorders that occur following repeat mTBI is viewed as the symptoms of CTE, the spectrum of chronic cognitive and neurobehavioral symptoms that occur after a single TBI is considered to represent distinct neurodegenerative diseases such as AD. These data support the suggestion that the multiple manifestations of TBI-induced neurodegenerative disorders be classified together as traumatic encephalopathy or trauma-induced neurodegeneration, regardless of the nature or frequency of the precipitating TBI.
Copyright © 2015 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Alzheimer's disease (AD); Amyloid (Aβ); Chronic traumatic encephalopathy (CTE); Dementia; Tau; Tauopathy; Traumatic brain injury (TBI)

Mesh:

Year:  2015        PMID: 26091850      PMCID: PMC4681695          DOI: 10.1016/j.expneurol.2015.06.015

Source DB:  PubMed          Journal:  Exp Neurol        ISSN: 0014-4886            Impact factor:   5.330


  78 in total

1.  Caspase inhibition therapy abolishes brain trauma-induced increases in Abeta peptide: implications for clinical outcome.

Authors:  Eric E Abrahamson; Milos D Ikonomovic; John R Ciallella; Caroline E Hope; William R Paljug; Barbara A Isanski; Dorothy G Flood; Robert S B Clark; Steven T DeKosky
Journal:  Exp Neurol       Date:  2005-11-21       Impact factor: 5.330

2.  Tau isoform profile and phosphorylation state in dementia pugilistica recapitulate Alzheimer's disease.

Authors:  M L Schmidt; V Zhukareva; K L Newell; V M Lee; J Q Trojanowski
Journal:  Acta Neuropathol       Date:  2001-05       Impact factor: 17.088

3.  Apolipoprotein E4 influences amyloid deposition but not cell loss after traumatic brain injury in a mouse model of Alzheimer's disease.

Authors:  Richard E Hartman; Helmut Laurer; Luca Longhi; Kelly R Bales; Steven M Paul; Tracy K McIntosh; David M Holtzman
Journal:  J Neurosci       Date:  2002-12-01       Impact factor: 6.167

4.  Documented head injury in early adulthood and risk of Alzheimer's disease and other dementias.

Authors:  B L Plassman; R J Havlik; D C Steffens; M J Helms; T N Newman; D Drosdick; C Phillips; B A Gau; K A Welsh-Bohmer; J R Burke; J M Guralnik; J C Breitner
Journal:  Neurology       Date:  2000-10-24       Impact factor: 9.910

5.  Traumatic brain injury causes frontotemporal dementia and TDP-43 proteolysis.

Authors:  H-K Wang; Y-C Lee; C-Y Huang; P-C Liliang; K Lu; H-J Chen; Y-C Li; K-J Tsai
Journal:  Neuroscience       Date:  2015-05-14       Impact factor: 3.590

6.  Alpha-synuclein immunoreactivity is present in axonal swellings in neuroaxonal dystrophy and acute traumatic brain injury.

Authors:  K L Newell; P Boyer; E Gomez-Tortosa; W Hobbs; E T Hedley-Whyte; J P Vonsattel; B T Hyman
Journal:  J Neuropathol Exp Neurol       Date:  1999-12       Impact factor: 3.685

7.  Tau immunohistochemistry in acute brain injury.

Authors:  C Smith; D I Graham; L S Murray; J A R Nicoll
Journal:  Neuropathol Appl Neurobiol       Date:  2003-10       Impact factor: 8.090

Review 8.  The amyloid hypothesis of Alzheimer's disease: progress and problems on the road to therapeutics.

Authors:  John Hardy; Dennis J Selkoe
Journal:  Science       Date:  2002-07-19       Impact factor: 47.728

9.  Amyloid beta accumulation in axons after traumatic brain injury in humans.

Authors:  Douglas H Smith; Xiao-Han Chen; Akira Iwata; David I Graham
Journal:  J Neurosurg       Date:  2003-05       Impact factor: 5.115

10.  Head injury as a risk factor for Alzheimer's disease: the evidence 10 years on; a partial replication.

Authors:  S Fleminger; D L Oliver; S Lovestone; S Rabe-Hesketh; A Giora
Journal:  J Neurol Neurosurg Psychiatry       Date:  2003-07       Impact factor: 10.154

View more
  59 in total

Review 1.  Making sense of gut feelings in the traumatic brain injury pathogenesis.

Authors:  Luiz Fernando Freire Royes; Fernando Gomez-Pinilla
Journal:  Neurosci Biobehav Rev       Date:  2019-05-16       Impact factor: 8.989

2.  History of traumatic brain injury interferes with accurate diagnosis of Alzheimer's dementia: a nation-wide case-control study.

Authors:  Tejus Pradeep; Michael J C Bray; Siddharth Arun; Lisa N Richey; Sahar Jahed; Barry R Bryant; Christian LoBue; Constantine G Lyketsos; Paul Kim; Matthew E Peters
Journal:  Int Rev Psychiatry       Date:  2019-11-11

3.  Concurrent Mild Traumatic Brain Injury and Posttraumatic Stress Disorder Is Associated With Elevated Tau Concentrations in Peripheral Blood Plasma.

Authors:  Cassandra L Pattinson; Jessica M Gill; Sara M Lippa; Tracey A Brickell; Louis M French; Rael T Lange
Journal:  J Trauma Stress       Date:  2019-07-10

4.  Association of Traumatic Brain Injury With Late-Life Neurodegenerative Conditions and Neuropathologic Findings.

Authors:  Paul K Crane; Laura E Gibbons; Kristen Dams-O'Connor; Emily Trittschuh; James B Leverenz; C Dirk Keene; Joshua Sonnen; Thomas J Montine; David A Bennett; Sue Leurgans; Julie A Schneider; Eric B Larson
Journal:  JAMA Neurol       Date:  2016-09-01       Impact factor: 18.302

Review 5.  Disordered APP metabolism and neurovasculature in trauma and aging: Combined risks for chronic neurodegenerative disorders.

Authors:  Milos D Ikonomovic; Zhiping Mi; Eric E Abrahamson
Journal:  Ageing Res Rev       Date:  2016-11-06       Impact factor: 10.895

Review 6.  A critical review of radiotracers in the positron emission tomography imaging of traumatic brain injury: FDG, tau, and amyloid imaging in mild traumatic brain injury and chronic traumatic encephalopathy.

Authors:  Cyrus Ayubcha; Mona-Elisabeth Revheim; Andrew Newberg; Mateen Moghbel; Chaitanya Rojulpote; Thomas J Werner; Abass Alavi
Journal:  Eur J Nucl Med Mol Imaging       Date:  2020-07-21       Impact factor: 9.236

7.  Single severe traumatic brain injury produces progressive pathology with ongoing contralateral white matter damage one year after injury.

Authors:  Francesca Pischiutta; Edoardo Micotti; Jennifer R Hay; Ines Marongiu; Eliana Sammali; Daniele Tolomeo; Gloria Vegliante; Nino Stocchetti; Gianluigi Forloni; Maria-Grazia De Simoni; William Stewart; Elisa R Zanier
Journal:  Exp Neurol       Date:  2017-11-07       Impact factor: 5.330

8.  A Novel Role for the Endocannabinoid System in Ameliorating Motivation for Alcohol Drinking and Negative Behavioral Affect after Traumatic Brain Injury in Rats.

Authors:  Elizabeth A Fucich; Jacques P Mayeux; M Adrienne McGinn; Nicholas W Gilpin; Scott Edwards; Patricia E Molina
Journal:  J Neurotrauma       Date:  2019-03-06       Impact factor: 5.269

9.  Inhibition of Endocannabinoid Degradation Improves Outcomes from Mild Traumatic Brain Injury: A Mechanistic Role for Synaptic Hyperexcitability.

Authors:  Jacques Mayeux; Paige Katz; Scott Edwards; Jason W Middleton; Patricia E Molina
Journal:  J Neurotrauma       Date:  2016-06-27       Impact factor: 5.269

Review 10.  Evidence to Consider Angiotensin II Receptor Blockers for the Treatment of Early Alzheimer's Disease.

Authors:  Juan M Saavedra
Journal:  Cell Mol Neurobiol       Date:  2016-03-18       Impact factor: 5.046

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.